IGF-1 LR3

IGF-1 LR3 (Long R3 IGF-1) is an 83-amino-acid analog of insulin-like growth factor 1 engineered with an extended N-terminal sequence and an arginine substitution at position 3. These structural modifications markedly reduce affinity for IGF-binding proteins relative to native IGF-1. In laboratory settings the compound is examined as a research tool for probing prolonged IGF-1 receptor engagement. It is supplied strictly for in-vitro and controlled laboratory research use only.

IGF-1 LR3 is studied for its high-affinity interaction with the IGF-1 receptor, triggering receptor autophosphorylation and recruitment of adaptor proteins. Downstream cascades under investigation include the PI3K/Akt pathway, linked to metabolic and survival signaling, and the MAPK/ERK pathway, associated with proliferative responses. Because the analog largely escapes sequestration by IGF-binding proteins, experimental systems can maintain elevated free ligand levels for extended observation of these cascades.

Investigators employ IGF-1 LR3 to examine cell proliferation, differentiation, and anabolic signaling networks in cultured mammalian cells and selected animal models. Research focuses on how sustained IGF-1 receptor activation influences protein synthesis machinery, cell-cycle progression, and tissue-specific growth pathways. The compound is also used to dissect differences between transient versus prolonged ligand exposure in receptor trafficking and desensitization studies.

Published laboratory work indicates that IGF-1 LR3 produces more durable IGF-1 receptor stimulation than equimolar native IGF-1 under identical culture conditions, attributable to reduced IGFBP binding. Model systems consistently show robust activation of Akt and MAPK phosphorylation when the analog is present. These observations have made IGF-1 LR3 a preferred reagent for experiments requiring continuous pathway drive without frequent media replenishment.

The N-terminal extension and Arg3 substitution of IGF-1 LR3 alter surface contacts that normally mediate high-affinity IGFBP interaction. In buffered aqueous solutions the peptide retains receptor-binding competence longer than native IGF-1, facilitating multi-day cell-culture protocols. Researchers document these properties when designing time-course and dose-response experiments that compare analog versus wild-type ligand behavior.

IGF-1 LR3 is handled under standard peptide laboratory practices, including cold-chain storage and reconstitution in appropriate sterile buffers for cell-culture or in-vitro assays. Investigators verify lot-specific purity and concentration by analytical methods before experimental use. All work remains confined to controlled research environments; the material is not intended for human or animal administration.